Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Should a patient with primary intracerebral haemorrhage receive antiplatelet or anticoagulant therapy?

× No keyword cloud information.

23 in total

1. Microbleeds may predict cerebral bleeding after stroke.

Authors: Kathryn Senior
Journal: Lancet Date: 2002-03-02 Impact factor: 79.321

2. Recurrent brain hemorrhage is more frequent than ischemic stroke after intracranial hemorrhage.

Authors: R D Bailey; R G Hart; O Benavente; L A Pearce
Journal: Neurology Date: 2001-03-27 Impact factor: 9.910

Review 3. Why do patients with atrial fibrillation not receive warfarin?

Authors: T J Bungard; W A Ghali; K K Teo; F A McAlister; R T Tsuyuki
Journal: Arch Intern Med Date: 2000-01-10

Review 4. Antithrombotic therapy in patients with any form of intracranial haemorrhage: a systematic review of the available controlled studies.

Authors: Sarah L Keir; Joanna M Wardlaw; Peter A G Sandercock; Zhengming Chen
Journal: Cerebrovasc Dis Date: 2002 Impact factor: 2.762

5. Managing the therapeutic dilemma: patients with spontaneous intracerebral hemorrhage and urgent need for anticoagulation.

Authors: M Bertram; M Bonsanto; W Hacke; S Schwab
Journal: J Neurol Date: 2000-03 Impact factor: 4.849

Review 6. Apolipoprotein E genotype and cerebral amyloid angiopathy-related hemorrhage.

Authors: M O McCarron; J A Nicoll
Journal: Ann N Y Acad Sci Date: 2000-04 Impact factor: 5.691

7. Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial.

Authors: Gregory W Albers; Hans-Christoph Diener; Lars Frison; Margaretha Grind; Mark Nevinson; Stephen Partridge; Jonathan L Halperin; Jay Horrow; S Bertil Olsson; Palle Petersen; Alec Vahanian
Journal: JAMA Date: 2005-02-09 Impact factor: 56.272

8. Risk of early death and recurrent stroke and effect of heparin in 3169 patients with acute ischemic stroke and atrial fibrillation in the International Stroke Trial.

Authors: R Saxena; S Lewis; E Berge; P A Sandercock; P J Koudstaal
Journal: Stroke Date: 2001-10 Impact factor: 7.914

9. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack.

Authors:
Journal: Lancet Date: 2001-09-29 Impact factor: 79.321

Should a patient with primary intracerebral haemorrhage receive antiplatelet or anticoagulant therapy?

1. Microbleeds may predict cerebral bleeding after stroke.

2. Recurrent brain hemorrhage is more frequent than ischemic stroke after intracranial hemorrhage.

Review 3. Why do patients with atrial fibrillation not receive warfarin?

Review 4. Antithrombotic therapy in patients with any form of intracranial haemorrhage: a systematic review of the available controlled studies.

5. Managing the therapeutic dilemma: patients with spontaneous intracerebral hemorrhage and urgent need for anticoagulation.

Review 6. Apolipoprotein E genotype and cerebral amyloid angiopathy-related hemorrhage.

7. Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial.

8. Risk of early death and recurrent stroke and effect of heparin in 3169 patients with acute ischemic stroke and atrial fibrillation in the International Stroke Trial.

9. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack.

10. Long-term prognosis after recovery from primary intracerebral hemorrhage.

1. The risk of recurrent stroke after intracerebral haemorrhage.

Review 2. Antithrombotic medicines following intracerebral haemorrhage: where's the evidence?

3. Quality of life and depression 3 months after intracerebral hemorrhage.